Comprehensive Genomic Profiling Of Pancreatic Cancer
John Strickler, M.D. Assistant Professor Of Medicine At Duke Cancer Institute, Discusses Comprehensive Genomic Profiling Of Pancreatic Cancer. At The 2019 Gastrointestinal Cancers Symposium In San Fra... Author: obr Added: 02/07/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 7, 2019 Category: Cancer & Oncology Source Type: podcasts

The Importance Of Genomic Profiling In Treating Colorectal Cancer
John Strickler, M.D. Assistant Professor Of Medicine At Duke Cancer Institute, Discusses The Importance Of Genomic Profiling In Treating Colorectal Cancer. At The 2019 Gastrointestinal Cancers Symposi... Author: obr Added: 02/07/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 7, 2019 Category: Cancer & Oncology Source Type: podcasts

KEYNOTE-181 Esophageal Cancer Study
John Strickler, M.D. Assistant Professor Of Medicine At Duke Cancer Institute, Discusses KEYNOTE-181 Esophageal Cancer Study. At The 2019 Gastrointestinal Cancers Symposium In San Francisco, CA On Jan... Author: obr Added: 02/07/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 7, 2019 Category: Cancer & Oncology Source Type: podcasts

Embolization Therapy For Liver Cancer
Ghassan Abou-Alfa, M.D. Attending Physician At Memorial Sloan Kettering Cancer Center, Discusses Embolization Therapy For Liver Cancer. At The 2019 Gastrointestinal Cancers Symposium In San Francisco,... Author: obr Added: 02/07/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 7, 2019 Category: Cancer & Oncology Source Type: podcasts

Data On Combining TKIs & Checkpoint Inhibitors In The Treatment Of Liver Cancer
Ghassan Abou-Alfa, M.D. Attending Physician At Memorial Sloan Kettering Cancer Center, Discusses Data On Combining TKIs & Checkpoint Inhibitors In The Treatment Of Liver Cancer. At The 2019 Gastrointe... Author: obr Added: 02/07/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 7, 2019 Category: Cancer & Oncology Source Type: podcasts

Checkpoint Inhibitors In The Treatment Of Liver Cancer
Ghassan Abou-Alfa, M.D. Attending Physician At Memorial Sloan Kettering Cancer Center, Discusses Checkpoint Inhibitors In The Treatment Of Liver Cancer. At The 2019 Gastrointestinal Cancers Symposium ... Author: obr Added: 02/07/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 7, 2019 Category: Cancer & Oncology Source Type: podcasts

New Therapies In The Treatment Of Liver Cancer
Ghassan Abou-Alfa, M.D. Attending Physician At Memorial Sloan Kettering Cancer Center Discusses, New Therapies In The Treatment Of Liver Cancer. At The 2019 Gastrointestinal Cancers Symposium In San F... Author: obr Added: 02/07/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 7, 2019 Category: Cancer & Oncology Source Type: podcasts

Discussing PARP Inhibitors & PEGPH20 Stroma Disrupting Agents
Bassel El-Rayes, M.D. Professor & Vice Chair For Clinical Research, Department Of Hematology & Medical Oncology Emory University School Of Medicine, John Kauffman Family Professor For Pancreatic Cance... Author: obr Added: 02/07/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 7, 2019 Category: Cancer & Oncology Source Type: podcasts

Advantages With Upfront Chemotherapy
Bassel El-Rayes, M.D. Professor & Vice Chair For Clinical Research, Department Of Hematology & Medical Oncology Emory University School Of Medicine, John Kauffman Family Professor For Pancreatic Cance... Author: obr Added: 02/07/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 7, 2019 Category: Cancer & Oncology Source Type: podcasts

Everybody With Pancreatic Cancer Recommended To Get BRCA Testing
Bassel El-Rayes, M.D. Professor & Vice Chair For Clinical Research, Department Of Hematology & Medical Oncology Emory University School Of Medicine, John Kauffman Family Professor For Pancreatic Cance... Author: obr Added: 02/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2019 Category: Cancer & Oncology Source Type: podcasts

Good News In Pancreatic Cancer
Bassel El-Rayes, M.D. Professor & Vice Chair For Clinical Research, Department Of Hematology & Medical Oncology Emory University School Of Medicine, John Kauffman Family Professor For Pancreatic Cance... Author: obr Added: 02/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2019 Category: Cancer & Oncology Source Type: podcasts

Elaborating On The Importance Of Precision Medicine In Gastric Cancers
Martine Extermann, M.D. Program Leader In The Senior Adult Oncology Program, Moffit Cancer Center, Discusses The Importance Of Precision Medicine In Gastric Cancers. At The 2019 Gastrointestinal Cance... Author: obr Added: 02/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2019 Category: Cancer & Oncology Source Type: podcasts

Elderly Patients Benefit From Third Line Metastatic Gastric Cancer Study
Martine Extermann, M.D. Program Leader In The Senior Adult Oncology Program, Moffit Cancer Center, Discusses Elderly Patients Benefit From Third Line Metastatic Gastric Cancer Study. At The 2019 Gastr... Author: obr Added: 02/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2019 Category: Cancer & Oncology Source Type: podcasts

Thoughts On Third Line Study For Metastatic Gastric Cancer
Martine Extermann, M.D. Program Leader In The Senior Adult Oncology Program, Moffit Cancer Center, Discusses Thoughts On Third Line Study For Metastatic Gastric Cancer. At The 2019 Gastrointestinal Ca... Author: obr Added: 02/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2019 Category: Cancer & Oncology Source Type: podcasts

Correlation Between Modified Resist Criteria In HCC & Overall Survival In REFLECT Study
Raymond Wadlow, M.D. Medical Oncologist At Inova Fairfax Hospital Discusses Correlation Between Modified Resist Criteria In HCC & Overall Survival In REFLECT Study. At The 2019 Gastrointestinal Cancer... Author: obr Added: 02/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2019 Category: Cancer & Oncology Source Type: podcasts

Discussing REFLECT Phase 3 Study Utilizing Lenvatinib & Recent Approval Of Cabozantinib
Raymond Wadlow, M.D. Medical Oncologist At Inova Fairfax Hospital Discusses REFLECT Phase 3 Study Utilizing Lenvatinib & Recent Approval Of Cabozantinib. At The 2019 Gastrointestinal Cancers Symposium... Author: obr Added: 02/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2019 Category: Cancer & Oncology Source Type: podcasts

Thoughts On CCTG CO.26 Canadian Study Demonstrating Immunotherapy Benefit In Colorectal Cancer
Raymond Wadlow, M.D. Medical Oncologist At Inova Fairfax Hospital Discusses Thoughts On CCTG CO.26 Canadian Study Demonstrating Immunotherapy Benefit In Colorectal Cancer. At The 2019 Gastrointestinal... Author: obr Added: 02/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2019 Category: Cancer & Oncology Source Type: podcasts

Data On KETNOTE-181 Esophageal Cancer Study Utilizing Pembrolizumab
Raymond Wadlow, M.D. Medical Oncologist At Inova Fairfax Hospital Discusses Data On KETNOTE-181 Esophageal Cancer Study Utilizing Pembrolizumab. At The 2019 Gastrointestinal Cancers Symposium In San F... Author: obr Added: 02/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2019 Category: Cancer & Oncology Source Type: podcasts

Data On Debrafenib & Trametinib Combo Therapy Study Testing For BRAFV600E Mutation
Zev Wainberg, M.D. Co-Director UCLA Gastro-Intestinal Oncology Program, Medical Director, UCLA Colorectal Hematology Oncology David Geffen School Of Medicine At UCLA Discusses Data On Debrafenib & Tra... Author: obr Added: 02/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2019 Category: Cancer & Oncology Source Type: podcasts

Discussing REACHIN Study Using Regorafenib In Biliary Tract Cancer
Zev Wainberg, M.D. Co-Director UCLA Gastro-Intestinal Oncology Program, Medical Director, UCLA Colorectal Hematology Oncology David Geffen School Of Medicine At UCLA Discusses REACHIN Study Using Rego... Author: obr Added: 02/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2019 Category: Cancer & Oncology Source Type: podcasts

Data Regarding Abraxane, Gemcitabine Plus Nivolumab Combo Study In Pancreatic Cancer
Zev Wainberg, M.D. Co-Director UCLA Gastro-Intestinal Oncology Program, Medical Director, UCLA Colorectal Hematology Oncology David Geffen School Of Medicine At UCLA Discusses Data Regarding Abraxane,... Author: obr Added: 02/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2019 Category: Cancer & Oncology Source Type: podcasts

The Role Of TACE With Systemic Therapy In HCC
Richard Finn, MD Professor of Clinical Medicine, Department of Medicine, Division of Hematology/ Oncology, Geffen School of Medicine, UCLA discusses The Role Of TACE With Systemic Therapy In HCC. At T... Author: obr Added: 02/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2019 Category: Cancer & Oncology Source Type: podcasts

The Effectiveness Of Sorafenib In Newly Diagnosed HCC
Richard Finn, MD Professor of Clinical Medicine, Department of Medicine, Division of Hematology/ Oncology, Geffen School of Medicine, UCLA discusses The Effectiveness Of Sorafenib In Newly Diagnosed H... Author: obr Added: 02/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2019 Category: Cancer & Oncology Source Type: podcasts

Current Treatment Options & Sequencing Of TKIs In HCC
Richard Finn, MD Professor of Clinical Medicine, Department of Medicine, Division of Hematology/ Oncology, Geffen School of Medicine, UCLA discusses Current Treatment Options & Sequencing Of TKIs In H... Author: obr Added: 02/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2019 Category: Cancer & Oncology Source Type: podcasts

The Use Of Biomarkers In The Treatment Of Esophagogastric Cancer
David Ilson, MD, PhD Attending Physician, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College, Discusses The Use Of Biomarkers In The Treatment Of Esophagogast... Author: obr Added: 02/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2019 Category: Cancer & Oncology Source Type: podcasts

The Role Of I-O In Esophagogastric Cancer Treatment Algorithms
David Ilson, MD, PhD Attending Physician, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College, Discusses The Role Of I-O In Esophagogastric Cancer Treatment Al... Author: obr Added: 02/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2019 Category: Cancer & Oncology Source Type: podcasts

Pembrolizumab, Trastuzumab, Capecitabine & Oxaliplatin In HER2+ mEGA
David Ilson, MD, PhD Attending Physician, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College, Discusses Pembrolizumab, Trastuzumab, Capecitabine & Oxaliplatin... Author: obr Added: 02/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2019 Category: Cancer & Oncology Source Type: podcasts

Can Serum Tumor Markers Be Used in the Management of Lung Cancer_ [360p]
Dr. Edward S. Kim from the Levine Cancer Institute in Charlotte, NC describes the use of serum tumor markers in various types of cancer, and the lack of a useful serum tumor marker in lung cancer. Author: cancergrace Added: 02/05/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 5, 2019 Category: Cancer & Oncology Source Type: podcasts

SBRT as a Potential Alternative for Fit Patients with Early Stage Lung Cancer [360p]
Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, provides evidence for the use of stereotactic body radiation therapy as an alternative to surgery for operable early st... Author: cancergrace Added: 02/05/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 5, 2019 Category: Cancer & Oncology Source Type: podcasts

What is the Role of Molecular Marker Testing in the Adjuvant or Post-Op Setting_ [360p]
Dr. Edward S. Kim from the Levine Cancer Institute in Charlotte, NC discusses the feasibility of molecular marker testing and targeted therapy in the adjuvant or post-operative setting. Author: cancergrace Added: 02/05/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 5, 2019 Category: Cancer & Oncology Source Type: podcasts

How Checkpoint Inhibitors Are Impacting Treatment Algorithms In mCRC
Howard Hochster, MD, Associate Director for Clinical Research, Rutgers Cancer institute of New jersey, Director of Oncology Research, RWJBarnabas Health discusses, How Checkpoint Inhibitors Are Impact... Author: obr Added: 02/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 4, 2019 Category: Cancer & Oncology Source Type: podcasts

Next Generation Sequencing And mCRC Treatment Decisions
Howard Hochster, MD, Associate Director for Clinical Research, Rutgers Cancer institute of New jersey, Director of Oncology Research, RWJBarnabas Health discusses, Next Generation Sequencing And mCRC ... Author: obr Added: 02/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 4, 2019 Category: Cancer & Oncology Source Type: podcasts

The Management Of mCRC Patients Receiving Regorafenib
Howard Hochster, MD, Associate Director for Clinical Research, Rutgers Cancer institute of New jersey, Director of Oncology Research, RWJBarnabas Health discusses, The Management Of mCRC Patients Rece... Author: obr Added: 02/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 4, 2019 Category: Cancer & Oncology Source Type: podcasts

The Role Of Genetic Testing In mCRC
Howard Hochster, MD, Associate Director for Clinical Research, Rutgers Cancer institute of New jersey, Director of Oncology Research, RWJBarnabas Health discusses, The Role Of Genetic Testing In mCRC.... Author: obr Added: 02/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 4, 2019 Category: Cancer & Oncology Source Type: podcasts

How To Manage 2nd And 3rd Line mCRC Patients
Howard Hochster, MD, Associate Director for Clinical Research, Rutgers Cancer institute of New jersey, Director of Oncology Research, RWJBarnabas Health discusses, How To Manage 2nd And 3rd Line mCRC ... Author: obr Added: 02/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 4, 2019 Category: Cancer & Oncology Source Type: podcasts

Whether Regorafenib Is Becoming More Tolerable For mCRC Patients
Jeffrey A. Meyerhardt, MD, Professor, Medicine, Harvard Medical School Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute discusses, Whether Regorafenib Is Becoming More Tolerable Fo... Author: obr Added: 02/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 4, 2019 Category: Cancer & Oncology Source Type: podcasts

Genetic Testing In Newly Diagnosed mCRC
Jeffrey A. Meyerhardt, MD, Professor, Medicine, Harvard Medical School Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute discusses, Genetic Testing In Newly Diagnosed mCRC. At The 2... Author: obr Added: 02/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 4, 2019 Category: Cancer & Oncology Source Type: podcasts

Thoughts On Checkpoint Inhibitors In Adjuvant CRC
Jeffrey A. Meyerhardt, MD, Professor, Medicine, Harvard Medical School Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute discusses, Thoughts On Checkpoint Inhibitors In Adjuvant CRC... Author: obr Added: 02/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 4, 2019 Category: Cancer & Oncology Source Type: podcasts

Managing 2nd And 3rd Line mCRC Patients
Jeffrey A. Meyerhardt, MD, Professor, Medicine, Harvard Medical School Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute discusses, Managing 2nd And 3rd Line mCRC Patients. At The 2... Author: obr Added: 02/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 4, 2019 Category: Cancer & Oncology Source Type: podcasts

BEACON Study In BRAF Mutated Metastatic Colorectal Cancer
Jeffrey A. Meyerhardt, MD, Professor, Medicine, Harvard Medical School Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute discusses, BEACON Study In BRAF Mutated Metastatic Colorecta... Author: obr Added: 02/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 4, 2019 Category: Cancer & Oncology Source Type: podcasts

The Impact Of The ReDOS study In HCC
Nevena Damjanov, MD, Chief of GI Oncology, Abramson Cancer Center at Penn Presbyterian, University of Pennsylvania discusses, The Impact Of The ReDOS study In HCC. At The 2019 Gastrointestinal Cancers... Author: obr Added: 02/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 4, 2019 Category: Cancer & Oncology Source Type: podcasts

Sequencing TKIs In Hepatocellular Carcinoma (HCC)
Nevena Damjanov, MD, Chief of GI Oncology, Abramson Cancer Center at Penn Presbyterian, University of Pennsylvania discusses, Sequencing TKIs In Hepatocellular Carcinoma (HCC). At The 2019 Gastrointes... Author: obr Added: 02/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 4, 2019 Category: Cancer & Oncology Source Type: podcasts

Thoughts On The Role Of Systemic Therapy In HCC
Nevena Damjanov, MD, Chief of GI Oncology, Abramson Cancer Center at Penn Presbyterian, University of Pennsylvania discusses, Thoughts On The Role Of Systemic Therapy In HCC. At The 2019 Gastrointesti... Author: obr Added: 02/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 4, 2019 Category: Cancer & Oncology Source Type: podcasts

Stereotactic Body Radiation Therapy In Early Stage HCC
Nevena Damjanov, MD, Chief of GI Oncology, Abramson Cancer Center at Penn Presbyterian, University of Pennsylvania discusses, Stereotactic Body Radiation Therapy In Early Stage HCC. At The 2019 Gastro... Author: obr Added: 02/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 4, 2019 Category: Cancer & Oncology Source Type: podcasts

Screening Patients At High Risk For Pancreatic Cancer
Philip Philip MD, PhD, FRCP, Professor of Oncology, Wayne State University School of Medicine, Clinical Professor of Oncology, Barbara Ann Karmanos Cancer Institute, Discusses Screening Patients At Hi... Author: obr Added: 01/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 31, 2019 Category: Cancer & Oncology Source Type: podcasts

Opinion On NGS And BRCA Gene Testing In Pancreatic Cancer
Philip Philip MD, PhD, FRCP, Professor of Oncology, Wayne State University School of Medicine, Clinical Professor of Oncology, Barbara Ann Karmanos Cancer Institute, Discusses Opinion On NGS And BRCA ... Author: obr Added: 01/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 31, 2019 Category: Cancer & Oncology Source Type: podcasts

Neoadjuvant Chemotherapy & Upfront Surgery In Pancreatic Cancer
Philip Philip MD, PhD, FRCP, Professor of Oncology, Wayne State University School of Medicine, Clinical Professor of Oncology, Barbara Ann Karmanos Cancer Institute, Discusses Neoadjuvant Chemotherapy... Author: obr Added: 01/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 31, 2019 Category: Cancer & Oncology Source Type: podcasts

Promising Novel Therapies For Pancreatic Cancer
Philip Philip MD, PhD, FRCP, Professor of Oncology, Wayne State University School of Medicine, Clinical Professor of Oncology, Barbara Ann Karmanos Cancer Institute, Discusses Promising Novel Therapie... Author: obr Added: 01/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 31, 2019 Category: Cancer & Oncology Source Type: podcasts

Molecular Subtyping Of Pancreatic Cancer
Philip Philip MD, PhD, FRCP, Professor of Oncology, Wayne State University School of Medicine, Clinical Professor of Oncology, Barbara Ann Karmanos Cancer Institute, Discusses Molecular SubTyping Of P... Author: obr Added: 01/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 31, 2019 Category: Cancer & Oncology Source Type: podcasts

The Use Of Regorafenib In The Management Of Advanced CRC
Axel Grothey, MD, Consultant, West Cancer Center, University of Tennessee, Discusses The Use Of Regorafenib In The Management Of Advanced CRC. At The 2019 Gastrointestinal Cancers Symposium In San Fra... Author: obr Added: 01/29/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 29, 2019 Category: Cancer & Oncology Source Type: podcasts